Comparison

Mavorixafor European Partner

Item no. TMO-TQ0174-50mg
Manufacturer TargetMol
CASRN 558447-26-0
Amount 50 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 200 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Molecules
Format Powder
Specific against other
Purity 0,98
Smiles N(CC=1NC=2C(N1)=CC=CC2)(CCCCN)[C@@H]3C=4C(CCC3)=CC=CN4
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias AMD-070
Shipping Condition Cool pack
Available
Manufacturer - Targets
CXCR
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
349.47
Description
Mavorixafor (AMD-070) is an effective and selective antagonist of CXCR4, with an IC50 value of 13 nM against CXCR4 125I-SDF binding. Mavorixafor inhibits the replication of T-tropic HIV-1 (NL4.3 strain) in MT-4 cells (IC50 = 1 nM) and PBMCs (IC50 = 9 nM).
Pathways
Immunology/Inflammation|||Autophagy|||GPCR/G Protein

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?